Shares of INNOVATE Corp. (NYSE:VATE) rose sharply in today's pre-market trading.
INNOVATE announced the FDA approval of MediBeacon’s TGFR System For accurate kidney function testing.
INNOVATE shares jumped 19.4% to $6.10 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
